Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

1,549

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2015

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

BI 10773

Medium dose once daily

DRUG

Glimepiride

1-4 mg once daily

DRUG

Placebo

Placebo matching BI 10773

DRUG

Placebo

Placebo matching Glimepiride

Trial Locations (182)

Unknown

1245.28.10005 Boehringer Ingelheim Investigational Site, Phoenix

1245.28.10012 Boehringer Ingelheim Investigational Site, Phoenix

1245.28.10016 Boehringer Ingelheim Investigational Site, Hot Springs

1245.28.10003 Boehringer Ingelheim Investigational Site, Sacramento

1245.28.10021 Boehringer Ingelheim Investigational Site, West Hills

1245.28.10009 Boehringer Ingelheim Investigational Site, Bradednton

1245.28.10015 Boehringer Ingelheim Investigational Site, Tampa

1245.28.10033 Boehringer Ingelheim Investigational Site, Blue Ridge

1245.28.10026 Boehringer Ingelheim Investigational Site, Boise

1245.28.10007 Boehringer Ingelheim Investigational Site, Omaha

1245.28.10027 Boehringer Ingelheim Investigational Site, Henderson

1245.28.10014 Boehringer Ingelheim Investigational Site, Rochester

1245.28.10006 Boehringer Ingelheim Investigational Site, Shelby

1245.28.10011 Boehringer Ingelheim Investigational Site, Cincinnati

1245.28.10019 Boehringer Ingelheim Investigational Site, Cincinnati

1245.28.10004 Boehringer Ingelheim Investigational Site, Columbus

1245.28.10008 Boehringer Ingelheim Investigational Site, Perrysburg

1245.28.10020 Boehringer Ingelheim Investigational Site, Medford

1245.28.10017 Boehringer Ingelheim Investigational Site, Portland

1245.28.10031 Boehringer Ingelheim Investigational Site, Dallas

1245.28.10032 Boehringer Ingelheim Investigational Site, Longview

1245.28.10022 Boehringer Ingelheim Investigational Site, San Antonio

1245.28.10030 Boehringer Ingelheim Investigational Site, Draper

1245.28.10023 Boehringer Ingelheim Investigational Site, Salt Lake City

1245.28.10013 Boehringer Ingelheim Investigational Site, Kenosha

1245.28.54010 Boehringer Ingelheim Investigational Site, Buenos Aires

1245.28.54001 Boehringer Ingelheim Investigational Site, Capital Federal

1245.28.54002 Boehringer Ingelheim Investigational Site, Córdoba

1245.28.54003 Boehringer Ingelheim Investigational Site, Córdoba

1245.28.43006 Boehringer Ingelheim Investigational Site, Graz

1245.28.43005 Boehringer Ingelheim Investigational Site, Salzburg

1245.28.43001 Boehringer Ingelheim Investigational Site, Vienna

1245.28.43002 Boehringer Ingelheim Investigational Site, Vienna

1245.28.43003 Boehringer Ingelheim Investigational Site, Vienna

1245.28.43004 Boehringer Ingelheim Investigational Site, Vienna

1245.28.20074 Boehringer Ingelheim Investigational Site, Calgary

1245.28.20077 Boehringer Ingelheim Investigational Site, Calgary

1245.28.20075 Boehringer Ingelheim Investigational Site, Edmonton

1245.28.20084 Boehringer Ingelheim Investigational Site, Langley

1245.28.20082 Boehringer Ingelheim Investigational Site, Grand Falls-Windsor

1245.28.20016 Boehringer Ingelheim Investigational Site, Mount Pearl

1245.28.20079 Boehringer Ingelheim Investigational Site, St. John's

1245.28.20071 Boehringer Ingelheim Investigational Site, Halifax

1245.28.20080 Boehringer Ingelheim Investigational Site, Collingwood

1245.28.20083 Boehringer Ingelheim Investigational Site, Greater Sudbury

1245.28.20078 Boehringer Ingelheim Investigational Site, Stayner

1245.28.20005 Boehringer Ingelheim Investigational Site, Strathroy

1245.28.20072 Boehringer Ingelheim Investigational Site, Chicoutimi

1245.28.20081 Boehringer Ingelheim Investigational Site, Chicoutimi

1245.28.20085 Boehringer Ingelheim Investigational Site, Gatineau

1245.28.20043 Boehringer Ingelheim Investigational Site, Longueuil

1245.28.20070 Boehringer Ingelheim Investigational Site, Montreal

1245.28.20076 Boehringer Ingelheim Investigational Site, Québec

1245.28.20073 Boehringer Ingelheim Investigational Site, Sherbrooke

1245.28.20021 Boehringer Ingelheim Investigational Site, Trois-Rivières

1245.28.57007 Boehringer Ingelheim Investigational Site, Barranquilla

1245.28.57003 Boehringer Ingelheim Investigational Site, Bogotá

1245.28.57005 Boehringer Ingelheim Investigational Site, Bogotá

1245.28.57006 Boehringer Ingelheim Investigational Site, Floridablanca

1245.28.42003 Boehringer Ingelheim Investigational Site, Brno

1245.28.42005 Boehringer Ingelheim Investigational Site, Holice

1245.28.42002 Boehringer Ingelheim Investigational Site, Mladá Boleslav

1245.28.42008 Boehringer Ingelheim Investigational Site, Prague

1245.28.42001 Boehringer Ingelheim Investigational Site, Slaný

1245.28.42007 Boehringer Ingelheim Investigational Site, Slaný

1245.28.42004 Boehringer Ingelheim Investigational Site, Uherské Hradiště

1245.28.42006 Boehringer Ingelheim Investigational Site, Zlín

1245.28.72001 Boehringer Ingelheim Investigational Site, Helsinki

1245.28.72004 Boehringer Ingelheim Investigational Site, Joensuu

1245.28.72003 Boehringer Ingelheim Investigational Site, Oulu

1245.28.72002 Boehringer Ingelheim Investigational Site, Pori

1245.28.85201 Boehringer Ingelheim Investigational Site, Hong Kong

1245.28.85207 Boehringer Ingelheim Investigational Site, Hong Kong

1245.28.85202 Boehringer Ingelheim Investigational Site, Kowloon

1245.28.91206 Boehringer Ingelheim Investigational Site, Ahmedabad

1245.28.91202 Boehringer Ingelheim Investigational Site, Bangalore

1245.28.91204 Boehringer Ingelheim Investigational Site, Bangalore

1245.28.91205 Boehringer Ingelheim Investigational Site, Bangalore

1245.28.91208 Boehringer Ingelheim Investigational Site, Bangalore

1245.28.91201 Boehringer Ingelheim Investigational Site, Chennai

1245.28.91213 Boehringer Ingelheim Investigational Site, Chennai

1245.28.91203 Boehringer Ingelheim Investigational Site, Hyderabad

1245.28.91211 Boehringer Ingelheim Investigational Site, Kolkata

1245.28.91210 Boehringer Ingelheim Investigational Site, Mangalore

1245.28.91212 Boehringer Ingelheim Investigational Site, New Delhi

1245.28.91207 Boehringer Ingelheim Investigational Site, Pune

1245.28.91209 Boehringer Ingelheim Investigational Site, Uttar Pradesh

1245.28.39021 Boehringer Ingelheim Investigational Site, Cagliari

1245.28.39022 Boehringer Ingelheim Investigational Site, Chieri (to)

1245.28.39016 Boehringer Ingelheim Investigational Site, Lucca

1245.28.39018 Boehringer Ingelheim Investigational Site, Milan

1245.28.39019 Boehringer Ingelheim Investigational Site, Milan

1245.28.39017 Boehringer Ingelheim Investigational Site, Monserrato (ca)

1245.28.39023 Boehringer Ingelheim Investigational Site, Rimini

1245.28.39020 Boehringer Ingelheim Investigational Site, Salerno

1245.28.60003 Boehringer Ingelheim Investigational Site, Johor Bahru

1245.28.60006 Boehringer Ingelheim Investigational Site, Kelantan

1245.28.60005 Boehringer Ingelheim Investigational Site, Kuala Lumpur

1245.28.60009 Boehringer Ingelheim Investigational Site, Kuala Lumpur

1245.28.60004 Boehringer Ingelheim Investigational Site, Kuala Pahang

1245.28.60007 Boehringer Ingelheim Investigational Site, Perak

1245.28.60010 Boehringer Ingelheim Investigational Site, Pulau Pinang

1245.28.60001 Boehringer Ingelheim Investigational Site, Selangor Darul Ehsan

1245.28.52006 Boehringer Ingelheim Investigational Site, Aguascalientes

1245.28.52008 Boehringer Ingelheim Investigational Site, Cuautla

1245.28.52009 Boehringer Ingelheim Investigational Site, Guadalajara

1245.28.52007 Boehringer Ingelheim Investigational Site, México

1245.28.31008 Boehringer Ingelheim Investigational Site, 's-Hertogenbosch

1245.28.31020 Boehringer Ingelheim Investigational Site, Losser

1245.28.31014 Boehringer Ingelheim Investigational Site, Rotterdam

1245.28.47002 Boehringer Ingelheim Investigational Site, Hønefoss

1245.28.47001 Boehringer Ingelheim Investigational Site, Oslo

1245.28.47003 Boehringer Ingelheim Investigational Site, Sandefjord

1245.28.63016 Boehringer Ingelheim Investigational Site, Cavite City

1245.28.63013 Boehringer Ingelheim Investigational Site, Cebu City

1245.28.63020 Boehringer Ingelheim Investigational Site, Jaro Iloilo City

1245.28.63004 Boehringer Ingelheim Investigational Site, Manila

1245.28.63015 Boehringer Ingelheim Investigational Site, Manila

1245.28.63012 Boehringer Ingelheim Investigational Site, Pasig

1245.28.63011 Boehringer Ingelheim Investigational Site, Quezon City

1245.28.63010 Boehringer Ingelheim Investigational Site, Tacloban City

1245.28.63014 Boehringer Ingelheim Investigational Site, Tagbilaran City, Bohol

1245.28.35006 Boehringer Ingelheim Investigational Site, Amadora

1245.28.35002 Boehringer Ingelheim Investigational Site, Lisbon

1245.28.35012 Boehringer Ingelheim Investigational Site, Porto

1245.28.35016 Boehringer Ingelheim Investigational Site, Vila Nova de Gaia

1245.28.76019 Boehringer Ingelheim Investigational Site, Boksburg North

1245.28.76018 Boehringer Ingelheim Investigational Site, Bryanston

1245.28.76016 Boehringer Ingelheim Investigational Site, Cape Town

1245.28.76017 Boehringer Ingelheim Investigational Site, Cape Town

1245.28.76012 Boehringer Ingelheim Investigational Site, Durban

1245.28.76015 Boehringer Ingelheim Investigational Site, Durban

1245.28.76013 Boehringer Ingelheim Investigational Site, Krugersdorp

1245.28.76024 Boehringer Ingelheim Investigational Site, Lenasia

1245.28.76023 Boehringer Ingelheim Investigational Site, Lenasia South

1245.28.76014 Boehringer Ingelheim Investigational Site, Pretoria

1245.28.34004 Boehringer Ingelheim Investigational Site, Barcelona

1245.28.34011 Boehringer Ingelheim Investigational Site, Barcelona

1245.28.34002 Boehringer Ingelheim Investigational Site, Burjasot

1245.28.34003 Boehringer Ingelheim Investigational Site, Centelles

1245.28.34009 Boehringer Ingelheim Investigational Site, Granada

1245.28.34012 Boehringer Ingelheim Investigational Site, Madrid

1245.28.34013 Boehringer Ingelheim Investigational Site, Madrid

1245.28.34005 Boehringer Ingelheim Investigational Site, Mataró

1245.28.34001 Boehringer Ingelheim Investigational Site, Pineda de Mar

1245.28.34010 Boehringer Ingelheim Investigational Site, San Sebastián de los Reyes

1245.28.34006 Boehringer Ingelheim Investigational Site, Tarrega - Lleida

1245.28.46009 Boehringer Ingelheim Investigational Site, Borås

1245.28.46008 Boehringer Ingelheim Investigational Site, Lund

1245.28.46001 Boehringer Ingelheim Investigational Site, Malmo

1245.28.46005 Boehringer Ingelheim Investigational Site, Örebro

1245.28.46002 Boehringer Ingelheim Investigational Site, Stockholm

1245.28.46006 Boehringer Ingelheim Investigational Site, Stockholm

1245.28.46007 Boehringer Ingelheim Investigational Site, Stockholm

1245.28.46004 Boehringer Ingelheim Investigational Site, Uppsala

1245.28.41015 Boehringer Ingelheim Investigational Site, Ascona

1245.28.41017 Inselspital Bern, Bern

1245.28.88004 Boehringer Ingelheim Investigational Site, Changhua

1245.28.88003 Boehringer Ingelheim Investigational Site, Taichung

1245.28.88005 Boehringer Ingelheim Investigational Site, Tainan Hsien

1245.28.88001 Boehringer Ingelheim Investigational Site, Taipei

1245.28.88002 Boehringer Ingelheim Investigational Site, Taipei Hsien

1245.28.66006 Boehringer Ingelheim Investigational Site, Bangkok

1245.28.66007 Boehringer Ingelheim Investigational Site, Bangkok

1245.28.66004 Boehringer Ingelheim Investigational Site, Muang District

1245.28.66008 Boehringer Ingelheim Investigational Site, Nakhonratchasima

1245.28.44006 Boehringer Ingelheim Investigational Site, Addlestone

1245.28.44020 Boehringer Ingelheim Investigational Site, Ashford

1245.28.44008 Boehringer Ingelheim Investigational Site, Balham

1245.28.44035 Boehringer Ingelheim Investigational Site, Barnstable

1245.28.44016 Boehringer Ingelheim Investigational Site, Blackpool

1245.28.44021 Boehringer Ingelheim Investigational Site, Bradford-on-Avon

1245.28.44019 Boehringer Ingelheim Investigational Site, Burbage

1245.28.44027 Boehringer Ingelheim Investigational Site, Chestfield, Whitstable

1245.28.44011 Boehringer Ingelheim Investigational Site, Chippenham

1245.28.44022 Boehringer Ingelheim Investigational Site, Chippenham

1245.28.44043 Boehringer Ingelheim Investigational Site, Coventry

1245.28.44025 Boehringer Ingelheim Investigational Site, Doncaster

1245.28.44030 Boehringer Ingelheim Investigational Site, Ely

1245.28.44007 Boehringer Ingelheim Investigational Site, Midsomer Norton

1245.28.44023 Boehringer Ingelheim Investigational Site, Nantwich

1245.28.44017 Boehringer Ingelheim Investigational Site, Whitstable

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY